Megha Mehrotra
Overview
Explore the profile of Megha Mehrotra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
974
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Bishnu A, Mehrotra M, Dhadve A, Dimri S, De A, Ray P
Transl Oncol
. 2021 Aug;
14(11):101193.
PMID: 34365218
Therapy induced rewiring of signalling networks often lead to acquirement of platinum-resistance, thereby necessitating the use of non-platinum agents as second-line treatment particularly for epithelial ovarian cancer (EOC). A prior...
12.
Mody A, Tram K, Glidden D, Eshun-Wilson I, Sikombe K, Mehrotra M, et al.
Curr HIV/AIDS Rep
. 2021 May;
18(4):299-308.
PMID: 33948789
Purpose Of Review: Retention in care is both dynamic and longitudinal in nature, but current approaches to retention often reduce these complex histories into cross-sectional metrics that obscure the nuanced...
13.
Hojilla J, Satre D, Glidden D, McMahan V, Gandhi M, Defechereux P, et al.
J Acquir Immune Defic Syndr
. 2019 Feb;
81(1):78-82.
PMID: 30730359
Background: Concomitant use of cocaine and HIV pre-exposure prophylaxis (PrEP) raises important clinical questions around adherence, retention in care, and renal toxicity. Methods: We assessed the associations of confirmed cocaine...
14.
Spinelli M, Glidden D, Rodrigues W, Wang G, Vincent M, Okochi H, et al.
AIDS
. 2019 Jan;
33(5):867-872.
PMID: 30649051
Objective: We examined the relationship between urine tenofovir (TFV) levels measured with a novel immunoassay, which permits point-of-care testing, with HIV seroconversion and objective adherence metrics in a large preexposure...
15.
Jotwani V, Scherzer R, Glidden D, Mehrotra M, Defechereux P, Liu A, et al.
J Acquir Immune Defic Syndr
. 2018 May;
78(2):169-174.
PMID: 29767638
Background: Pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate (TDF) and emtricitabine (FTC) is becoming increasingly adopted for HIV prevention. Tenofovir can cause proximal tubular damage and chronic kidney disease in...
16.
Hojilla J, Vlahov D, Glidden D, Amico K, Mehrotra M, Hance R, et al.
J Int AIDS Soc
. 2018 Mar;
21(3):e25103.
PMID: 29577616
Introduction: Stimulant and heavy alcohol use are prevalent and associated with elevated risk for HIV seroconversion among men who have sex with men (MSM) and transgender women. In addition, each...
17.
Hojilla J, Mehrotra M, Truong H, Glidden D, Amico K, McMahan V, et al.
AIDS Care
. 2017 Oct;
30(4):466-472.
PMID: 29082776
HIV pre-exposure prophyalxis (PrEP) might lead individuals to view serodisclosure as unnecessary. We examined the prevalence of non-disclosure and lack of knowledge of partner status in a global cohort of...
18.
Truong H, Mehrotra M, Montoya O, Lama J, Guanira J, Casapia M, et al.
Sex Transm Dis
. 2017 Apr;
44(5):306-309.
PMID: 28407648
Exchange sex and higher education were associated with an increased likelihood of international sexual partnerships (ISPs). Exchange sex and older age were associated with an increased likelihood of condomless sex...
19.
Amico K, Mehrotra M, Avelino-Silva V, McMahan V, Veloso V, Anderson P, et al.
AIDS Behav
. 2016 Mar;
20(7):1535-40.
PMID: 26992393
Monitoring adherence to pre-exposure prophylaxis (PrEP) is part of the recommended package for PrEP prescribing, yet ongoing concerns about how to do so confidently are exacerbated by gross discrepancies in...
20.
Defechereux P, Mehrotra M, Liu A, McMahan V, Glidden D, Mayer K, et al.
AIDS Behav
. 2015 Jun;
20(7):1478-88.
PMID: 26078115
We conducted a longitudinal and cross-sectional analysis of depressive symptomology in iPrEx, a randomized, placebo-controlled trial of daily, oral FTC/TDF HIV pre-exposure prophylaxis (PrEP) in men and transgender women who...